Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Cell MedX Corp. | form10q.htm |
| EX-32.2 - CERTIFICATION - Cell MedX Corp. | ex322.htm |
| EX-31.2 - CERTIFICATION - Cell MedX Corp. | ex312.htm |
| EX-31.1 - CERTIFICATION - Cell MedX Corp. | ex311.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cell MedX Corp. (the “Company”) on Form 10-Q for the period ending November 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
|
|
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
|
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: January 17, 2017
/s/ Frank E. McEnulty
Frank E. McEnulty
Chief Executive Officer and President
(Principal Executive Officer)